Zilucoplan for Severe gMG Exacerbations — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Zilucoplan for Severe gMG Exacerbations — Stella

Home/Generalized Myasthenia Gravis (gMG)/

View on ClinicalTrials.gov

Recruiting

Back to Generalized Myasthenia Gravis (gMG) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

The Ohio State University, Columbus, Ohio

Key details

Phase

Large-scale testing

Sponsor

Miriam Freimer

Collaborators

UCB Pharma

Enrollment target

~15 participants

Started

January 2026

Primary completion

December 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.